AI Tumor Board Presentations

The tumor board is the central deliberative forum of multidisciplinary oncology care. In the 20 to 30 minutes typically allocated per case, a medical oncologist, radiation oncologist, surgical oncologist, pathologist, radiologist, and specialist nurse must align on staging, discuss the evidence base for competing treatment options, and reach a defensible recommendation. The case presenter — whether a fellow, a surgical resident, or an attending — has a narrow window to present the clinical context clearly enough to make that deliberation efficient. SlideCraft Pro generates tumor board presentations structured to meet exactly this need.

The AI produces tumor board case slides that follow the standard MDT review format. The opening slide summarizes patient demographics, performance status (ECOG or KPS), cancer type, and reason for MDT review. Subsequent slides cover clinical presentation summary, relevant oncologic history (prior treatments, response, toxicity), and current status. Imaging staging slides present key findings by modality — CT, MRI, PET/CT — with staging summary using the appropriate system (TNM, FIGO for gynecologic, Ann Arbor for lymphoma). Pathology and molecular results slides cover histologic subtype, grade, relevant immunohistochemistry, and actionable molecular biomarkers.

Treatment options slides present the competing management approaches with supporting evidence level — resectability assessment and surgical approach for GI tumors, neoadjuvant versus adjuvant chemotherapy decision for breast cancer, stereotactic radiosurgery versus hypofractionation versus conventional fractionation for CNS tumors. A final recommendation slide frames the MDT consensus position with explicit rationale.

Neuro-oncology, GI oncology, breast, lung, head and neck, GU oncology, and hematologic malignancy tumor boards all have different conventions, and the Deck Rules feature allows the presenter to inject institution-specific MDT format language. The PPTX export integrates with hospital tumor board management systems and electronic MDT platforms.